A Clinical Study to Assess the Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Healthy Volunteers.
Latest Information Update: 08 Nov 2021
Price :
$35 *
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Adimmune Corporation
- 01 Mar 2012 6-month follow-up results published in Clinical and Vaccine Immunology.
- 19 Jan 2012 Actual end date Apr 2010 added as reported by ClinicalTrials.gov (Parent trial: NCT01003145).
- 19 Jan 2012 Actual end date Apr 2010 added as reported by ClinicalTrials.gov (Parent trial: NCT01003145).